Danish Startup Biosyntia grabs €1.7M to Inject Synthetic Biology into Vitamin Production

20/05/2015 - 2 minutes

Biosyntia is a Danish start-up company in the synthetic biology field. The company aims at replacing chemical-based vitamin production by sustainable and fermentation-based processes. Yesterday, during our Denmark Biotech Tour, we met Andreas Laustsen, one of Biosyntia‘ founders who told us that the company has just raised €1,7M from Novo Seeds.

The startup was founded in 2012 by a group of highly-skilled young scientists, including the youngest danish professor ever and the awarded Denmark’s coolest engineer! Biosyntia developped biocatalysts at unprecedented speed and efficiency by employing a patent pending high-throughput screening technology.

As Laustsen outlined very well: “When trying to find new biocatalytic enzymes or pathways, others look for the needle in the haystack by going through the haystack straw by straw. Our technology has enabled us to burn down the haystack”

The company already received numerous grants and recognitions (such as making the Top 5 most innovative start-up companies in Europe) and has now finished a €1.7M financing round to establish a biobased vitamin production platform.

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
ADVERTISEMENT
Do you want to remove this advert? Become a member!
ADVERTISEMENT
Do you want to remove this advert? Become a member!

You might also be interested in the following: